Answer
Suitability depends on severity and interacting medicines. It is contraindicated in haemodialysis and severe liver impairment, with additional restrictions involving strong CYP3A4 inhibitors.
Sources for this answer
- Solifenacin succinate/Tamsulosin hydrochloride 6 mg/0.4 mg Modified-release tablet — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.